First Header Logo Second Header Logo

Connection

Shahla Namak to Drug Approval

Back to Details
This is a "connection" page, showing publications Shahla Namak has written about Drug Approval.
Shahla Namak
Connection Strength
0.156
Drug Approval
  1. Feldman SR, Bagel J, Namak S. Biosimilars for Immune-Mediated Chronic Diseases in Primary Care: What a Practicing Physician Needs to Know. Am J Med Sci. 2018 May; 355(5):411-417.
    View in: PubMed
    Score: 0.156
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.